• Contact Form
  • help@soleburystrat.com
  • Login
Logo2
  • Events
  • Companies
  • Blog
  • Service
    • Help with Credentials
Logo2
Sign in with LinkedIn
Request new Password.
Presenter Access
Unsupported Browser. Please use Google Chrome, Mozilla Firefox, or Microsoft Edge to submit meeting requests. Microsoft Internet Explorer is not supported due to its outdated JavaScript engine.
Categories & Filter
  • All Posts
  • {{ value.title }}
  • Clear Categories



  • Preamble [SYSTEM]
  • Fund & Investor Interest
  • Street Moves
  • Solebury Trout Updates
  • Market Commentary
  • IPO News
  • Expert Interactions
  • Banker Comments & Notes
  • Conference Snippet
  • Industry Snippets
  • Social Media
  • Solebury Trout Talks

  • SoftBank Plans to Invest Billions in Biotech Stocks
  • In search of 'household healthcare brands of the future,' Foresite Capital raises $969M to satiate a tech-heavy appetite
  • OrbiMed, biopharma's biggest investor, closes $3.5B in three new private funds
  • Broadridge 2021 EDGAR Filing Calendar
  • Life Sci VC - The Record-Breaking Biotech Funding Tsunami Of 1H2020
  • SEC Proposes Amendments to Update Form 13F for Institutional Investment Managers; Amend Reporting Threshold to Reflect Today’s Equities Markets
  • Reuters - Hedge fund Hoplite Capital plans to shut down - letter
  • Nasdaq - Capital Markets Trends: Biotech
  • Pitchbook - 18 charts to illustrate US VC in 2018
  • New HBM Report - Analysis of FDA New Drug Approvals 2018 (and Multi-Year Trends)
  • WSJ - Biotech Startup Moderna Drops an Underwriter Ahead of IPO
  • Scott Davis & Carter Copeland At Melius - A Year into MiFID II
  • Solebury Trout BD takeaways from Boston BD Roundtable and Hamptons BD Panel

© Copyright 2023 by Solebury Strategic Communications | Current user: n/a, [en_US] | Privacy Policy